+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID04271956

Evaluating Zanubrutinib and Tislelizumab With or Without Sonrotoclax for Patients With Richter Transformation A Phase II Open-Label Multicenter Trial

Led by German CLL Study Group · Updated on 2026-08-20

83

Participants Needed

11

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of combining zanubrutinib, a BTK inhibitor, with tislelizumab, a PD-1 inhibitor, for treating patients with Richter Transformation RT, a serious complication in chronic lymphocytic leukemia CLL. RT is challenging to manage, with poor prognosis and limited success from conventional chemoimmunotherapy. This trial aims to explore new treatment options due to the urgent need for better therapies. The study involves two treatment groups one receiving tislelizumab plus zanubrutinib, and the other receiving tislelizumab, zanubrutinib, and sonrotoclax, a Bcl-2 inhibitor. Participants undergo induction with six 21-day cycles of assigned treatments, followed by six consolidation cycles on the same schedule. Those who respond continue on maintenance therapy with their assigned drugs every three weeks until disease progression, intolerance, or receiving stem cell transplantation. Participants will be closely monitored throughout the study, which lasts up to 15 months, with assessments including response rates after induction and consolidation, progression-free and overall survival, time to next treatment, and duration of response. Safety will be tracked by recording adverse events. The trial includes laboratory tests, imaging, and clinical evaluations to measure treatment effects and tolerability over time.

CONDITIONS

Brief Title

Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without Sonrotoclax for Patients With Richter Transformation

Research Team

B

Barbara Eichhorst, Prof.

O

Othman Al-Sawaf, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here